Navigation Links
Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
Date:4/17/2013

em disorders.

Forward-Looking Statements

This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, Omeros' expectations regarding that it may obtain orphan drug designation for OMS721; the potential indications that OMS721 may treat; the potential advantages of OMS721 over current treatments; when OMS721 will begin clinical development; that it will apply for orphan drug designation for OMS721 in Europe; and that Omeros may have capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 18, 2013. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and the Company assumes no obligation to update these forward-looking statements publicly, even if new information becomes available in the future.


'/>"/>
SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
2. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
3. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
4. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
5. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
6. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
7. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
8. Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
9. Omeros Announces Positive OMS302 Safety Data in Phase 3 Clinical Trial
10. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
11. Omeros to Present at the 24th Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014  Semler Scientific, Inc. (Nasdaq: ... assessment company that develops patented products that assist ... diseases, today reported financial results for the second ... "The second quarter of 2014 ... Doug Murphy-Chutorian , M.D., chief executive officer of ...
(Date:7/25/2014)... N.Y. , July 25, 2014 /PRNewswire-iReach/ -- Dr. ... clinic, GPM Pediatrics, reacts to a recent study, which ... Photo - http://photos.prnewswire.com/prnh/20140723/129709 ... exposed to severe stress are more likely than others to ... months before pregnancy." There were two specific types ...
(Date:7/24/2014)... , July 24, 2014  Restore Health, ... and compounded pharmaceuticals, announced that it is now ... unique to each individual based upon their particular ... by understanding the interaction between a patient,s genetics ... "We,re very excited to provide this new service ...
Breaking Medicine Technology:Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3
(Date:7/26/2014)... According to the "Get Rid Tattoo Naturally" book ... guide that provides readers with safe and natural methods ... teaches them how to fade dark colored tattoos, and ... home for drastic results. , Vkool reveals in ... step-by-step tutorials and product recommendations for treating different ...
(Date:7/25/2014)... (PRWEB) July 26, 2014 PersonalInjurySolicitorsIreland, ... legal help to people who have suffered from ... launch of both their new company, and a ... on the new website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , ... The focus of the company is always on ...
(Date:7/25/2014)... According to a new market research ... monitoring, thermography, ultrasound emission, lubricating oil analysis, corrosion ... Geography - Global Forecast to 2014 - 2020", ... is expected to reach $2.50 at a CAGR ... 117 market data Tables and 57 Figures spread ...
(Date:7/25/2014)... As reported by the New Orleans Advocate in ... (7/3), the state of Louisiana has recently seen a large ... cocaine. Officials believe the increase is due to a misconception ... marijuana. However, both doctors and police confirm that that belief ... call it “poison,” doctors have acknowledged that the Louisiana Poison ...
(Date:7/25/2014)... America (GSA) the nation,s largest interdisciplinary ... has chosen Heather M. Young, PhD, RN, FAAN, ... 2014 recipient of the Doris Schwartz Gerontological Nursing ... GSA,s Health Sciences Section, is given to a ... and sustained contribution to gerontological nursing research. , ...
Breaking Medicine News(10 mins):Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 2Health News:"Get Rid Tattoo Naturally" Book Review Exposes Jason Carter's Tattoo Removal Guide – Vkool.com 3Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Louisiana Recognizes Dangers of Synthetic Marijuana 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2
... Brigid Waldron-Perrine, Ph.D., a recent graduate from Wayne State University, ... at Wayne State University,s College of Liberal Arts and Sciences, ... to a higher power, it can help them rehabilitate. The ... Traumatic brain injury is a disruption of normal brain ...
... -- New mandatory safety standards for cribs in the United ... ensuring a safe environment for infants as they sleep," according ... and Human Development. Under the new Consumer Product Safety ... cribs will be banned, mattress supports will be stronger, crib ...
... LINDA, Calif. Health disparities between black Americans and ... medical journals. But one study shows that blacks who ... report a better quality of life than the average ... possible explanation for the difference. The research was conducted ...
... has confirmed that between 10-20% of breast cancers classified ... when and why breast cancers may be misclassified has ... with breast cancer. Its findings are published online in ... A woman diagnosed with breast cancer can be ...
... June 27, 2011 In today,s society where access to ... appropriate media usage for their children and how media consumption ... Dimitri A. Christakis, MD, MPH and Dr. Michelle M. Garrison, ... of media and assess how media usage can lead to ...
... NEW YORK (June 27, 2011) -- As required under the ... people will soon be added to the ranks of the ... a different, potentially problematic trend that could end up hampering ... accepting fewer and fewer patients with health insurance, according to ...
Cached Medicine News:Health News:Religion benefits traumatic brain injury victims, Wayne State University research finds 2Health News:New Crib Safety Rules to Take Effect 2Health News:Black members of Adventist church defy health disparities, study shows 2Health News:Studies examine impact of media use among youth, recommend preventative measures 2Health News:Studies examine impact of media use among youth, recommend preventative measures 3Health News:Surprising drop in physicians' willingness to accept patients with insurance 2
... long-standing tradition of the original Hoffmann® ... today's surgeon with advanced technology and ... loaded snap fit mechanism allows the ... rods or pins providing versatile intraoperative ...
... OMNIPAQUE is an X-ray contrast ... and children for: angiography, urography, ... computed tomography of the basal ... endoscopic retrograde cholangio (pancreato) graphy ...
... contrast agent FDA-approved for administration by power ... IV contrast media for MR imaging of ... has convenient packaging options for just the ... problem-free delivery. You can trust OptiMARK ...
... was launched in the U.S. in 1993 ... nervous system (CNS) to detect lesions of ... OMNISCAN has since received approval for adult ... CNS and body indications. OMNISCAN comes in ...
Medicine Products: